Company researchers compare EPA uptake from algal oil and krill oil.
An algal oil ingredient from Qualitas Health (Jerusalem, Israel) appears to encourage EPA uptake into human blood plasma more so than krill oil.
Derived from Nannochloropsis oculata microalgae, Almega PL is rich in omega-3 EPA. And its unique structure of polar lipids may be its key to success. In a single-dose crossover study, human subjects consumed 1.5 g of either algal oil or krill oil with a high-fat breakfast. Blood analysis up to 10 hours after consumption showed greater uptake of EPA and greater maximum change in EPA concentration from baseline with algal oil. EPA levels increased with algal oil as much as 100% more than with krill oil.
The algal oil ingredient contains omega-3 EPA, but krill oil contains both EPA and DHA. While this could be a reason for krill’s lower EPA readings, the researchers acknowledge that “[omega-3] polyunsaturated fatty acids within glycolipids, as found in algal oil but not krill oil, are an effective system for delivering EPA to humans.”
Whether or not the polar lipid mechanism is more effective than that used in other oils remains to be determined. Almega PL is marketed as a vegetarian source of omega-3 nutrition that does not impact ocean wildlife.
Rousselot to showcase new collagen peptide research and targeted solutions at Vitafoods Europe 2024
April 25th 2024The company will be highlighting new research that demonstrates the ability of its Peptan collagen peptide brand to support sleep quality, reduce gastrointestinal discomfort, and enhance skin health, including density, hydration, and elasticity.
The Nutritional Outlook Podcast Episode 29: 2024 Ingredients to Watch
January 31st 2024Nutritional Outlook interviews Scott Dicker, market insights director from market researcher SPINS, about ingredients and product categories nutraceutical and nutrition product manufacturers should watch in 2024.